Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization.

No abstract is available for this paper.

• Publication year

  1957

• Venue

  American journal of hygiene

• Publication date

  1957-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/OXFORDJOURNALS.AJE.A119901PMID 13478578
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiologic aspects of infection in infants and young children.

  1957cited by this paper
• Human Amnion Cell Cultures; Susceptibility to Viruses and Use in Primary Virus Isolations.∗

  1957cited by this paper
• Recovery of cytopathogenic agent from chimpanzees with coryza.

  1956cited by this paper
• ASSOCIATION OF A NEW TYPE OF CYTOPATHOGENIC MYXOVIRUS WITH INFANTILE CROUP

  1956cited by this paper
• Propagation of Measles Virus in Human Carcinoma Cells

  1956cited by this paper
• Propagation in a Fluid Medium of a Human Epidermoid Carcinoma, Strain KB

  1955cited by this paper
• Propagation in Tissue Cultures of Cytopathogenic Agents from Patients with Measles.†

  1954cited by this paper
• Cytolytic Effects of Mumps Virus in Tissue Cultures of Epithelial Cells.∗

  1954cited by this paper
• Continuous Subcultivation of Epithelial-like Cells from Normal Human Tissues.∗

  1954cited by this paper
• A simplified method of determining the sizes of viruses in impure preparations.

  1952cited by this paper
• Nutrition of Animal Cells in Tissue Culture. I. Initial Studies on a Synthetic Medium.∗,†

  1950cited by this paper
• Sampling variation of the fifty percent end-point, determined by the Reed-Muench (Behrens) method.

  1950cited by this paper

• The Complexity of Immunoglobulin A Immune Responses in Respiratory Syncytial Virus Infection.

  2026cites this paper
• Respiratory Syncytial Virus Prevalence and Genotypic Distribution in the Countries of the Former Soviet Union: A Systematic Review and Meta-Analysis

  2026cites this paper
• RSV vaccine development: advances and fusion protein-focused strategies

  2026cites this paper
• Preliminary analysis of combined vaccines against respiratory syncytial virus and human metapneumovirus

  2025cites this paper
• Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children

  2025cites this paper
• Análisis preliminar de las vacunas combinadas frente al virus respiratorio sincitial y el metapneumovirus humano

  2025cites this paper
• Molecular Mechanisms of Respiratory Syncytial Virus Pathogenesis.

  2025cites this paper
• MODELING RESPIRATORY VIRAL INFECTIONS ACTUAL IN THE FIRST QUARTER OF THE XXI CENTURY: FROM PRIMARY EPITHELIAL CULTURES TO ORGANOIDS

  2025cites this paper
• Deciphering the Role of Macrophages in RSV Infection and Disease

  2025cites this paper
• Genome-Wide Analyses of Human Respiratory Syncytial Viruses Provide Insights into Evolutionary Dynamics

  2025cites this paper
• Insights into the Currently Available Drugs and Investigational Compounds Against RSV with a Focus on Their Drug-Resistance Profiles

  2025cites this paper
• The Story behind the Science: On the discovery of respiratory syncytial virus

  2025cites this paper
• Molecular and Cellular Mechanisms of Respiratory Syncytial Viral Infection: Its Implications for Prophylactic and Therapeutic Pharmaceuticals

  2025cites this paper
• Respiratory syncytial virus (RSV): prevention and antiviral therapeutic strategies

  2025cites this paper
• Exploring Therapeutic Targets From Spreading Patterns Against Respiratory Syncytial Virus

  2025cites this paper
• A novel bispecific nanobody protects mice against RSV infection via intranasal administration

  2025cites this paper
• The Story behind the Science: Shining a light on the path to discovery

  2025cites this paper
• Optimizing RSV Treatment: Insights into Targeted Drug Delivery Strategies and Public Health Implications

  2025cites this paper
• Liquid-liquid phase separation mediated immune evasion of RSV against OAS-RNase L pathway

  2025cites this paper
• A contemporary strain of RSV activates primary human monocytes after abortive infection

  2025cites this paper
• A Comparative Profile of the Burden of Human Metapneumovirus, Respiratory Syncytial Virus, and Influenza in the HIVE Cohort, 2010–2022

  2025cites this paper
• Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children.

  2025cites this paper
• Advances in development of antiviral strategies against respiratory syncytial virus

  2025influential citation
• Ziresovir: un potente inhibidor selectivo y oral de la proteína de fusión (F) del virus respiratorio sincitial

  2025cites this paper
• Nanotechnology-driven enhancement and modulation of immune responses in monkeypox and respiratory syncytial virus nanovaccine research.

  2025cites this paper
• Viral Titer of Respiratory Syncytial Virus in the Nasal Cavity in Different Sites in Children and Adults

  2025cites this paper
• The Evolving Landscape of Respiratory Syncytial Virus (RSV) Prophylaxis in Infants

  2025cites this paper
• Review of the past and present status of respiratory syncytial virus and rotavirus infections that commonly affect children.

  2024cites this paper
• The disease burden of respiratory syncytial virus in older adults

  2024cites this paper
• Vaccines against respiratory syncytial virus

  2024cites this paper
• RSV Vaccination in the adult pulmonary patient.

  2024cites this paper
• Identification of distinct genotypes in circulating RSV A strains based on variants on the virus replication-associated genes

  2024cites this paper
• All Eyes on the Prefusion-Stabilized F Construct, but Are We Missing the Potential of Alternative Targets for Respiratory Syncytial Virus Vaccine Design?

  2024cites this paper
• From Forgotten Pathogen to Target for New Vaccines: What Clinicians Need to Know about Respiratory Syncytial Virus Infection in Older Adults

  2024cites this paper
• Situación actual de las vacunas atenuadas intranasales frente al virus respiratorio sincitial en la población infantil

  2024cites this paper
• Respiratory Syncytial Virus: Biology, Genetic Diversity, and Perspective Control Preparations

  2024cites this paper
• Respiratory-syncitial virus: biology, genetic diversity and perspective control preparations

  2024cites this paper
• Arexvy: A Comprehensive Review of the Respiratory Syncytial Virus Vaccine for Revolutionary Protection

  2024cites this paper
• Application Value of Serum Cytokines in Respiratory Syncytial Virus Pneumonia in Children

  2024cites this paper
• Biology of human respiratory syncytial virus: Current perspectives in immune response and mechanisms against the virus

  2024cites this paper
• Early-life respiratory syncytial virus disease and long-term respiratory health.

  2024cites this paper
• Epidemiology and Disease Burden of Respiratory Syncytial Virus Infection in Adults

  2024cites this paper
• Current situation of intranasal attenuated vaccines against respiratory syncytial virus in the child population

  2024cites this paper
• A Retrospective Public Health Assessment and Management in Terms of the Social and Clinical Risk Factors of Respiratory Syncytial Virus Infection in Northern Canada

  2024cites this paper
• Comparative analysis of acute respiratory infections of viral etiology in children under 6 months with and without nirsevimab in the Balearic Islands (2022-2023 and 2023-2024).

  2024cites this paper
• How old is bronchiolitis?

  2024cites this paper
• Investigating the antiviral activity of Erigeron annuus (L.) Pers extract against RSV and examining its active components.

  2024cites this paper
• Hybrid Predictive Machine Learning Model for the Prediction of Immunodominant Peptides of Respiratory Syncytial Virus

  2024cites this paper
• Identification of distinct genotypes in circulating RSV A strains based on variants in the virus replication-associated genes

  2024cites this paper
• Respiratory Syncytial Virus: Epidemiology, Burden of Disease, and Clinical Update.

  2024cites this paper
• Landscape of respiratory syncytial virus

  2024cites this paper
• Microbiological and epidemiological features of respiratory syncytial virus

  2024cites this paper
• Favorable Nonclinical Safety Profile of RSVpreF Bivalent Vaccine in Rats and Rabbits

  2024cites this paper
• A Review of Respiratory Syncytial Virus Epidemiology Among Children: Linking Effective Prevention to Vulnerable Populations.

  2024cites this paper
• Análisis comparativo de las infecciones respiratorias agudas de etiología viral en menores de 6 meses con y sin nirsevimab en Baleares (2022-2023 y 2023-2024)

  2024cites this paper
• Current state and challenges in respiratory syncytial virus drug discovery and development.

  2023cites this paper
• Interactions of heparin with key glycoproteins of human respiratory syncytial virus

  2023cites this paper
• Vaccination for Respiratory Syncytial Virus: A Narrative Review and Primer for Clinicians

  2023cites this paper
• Respiratory Syncytial Virus Infections in Neonates: A Persisting Problem

  2023cites this paper
• Review and Update of Active and Passive Immunization Against Respiratory Syncytial Virus

  2023cites this paper
• Situación actual y perspectivas de futuro de las vacunas frente al virus respiratorio sincitial

  2023cites this paper
• Potentiality of bioactive compounds as inhibitor of M protein and F protein function of human respiratory syncytial virus

  2023cites this paper
• Respiratory Viruses and Virus-like Particle Vaccine Development: How Far Have We Advanced?

  2023cites this paper
• Nirsevimab-resistant respiratory syncytial virus strains are rare but there.

  2023cites this paper
• Viral Respiratory Infections in Newborns After The Pandemic

  2023cites this paper
• Mucosal Application of a Low-Energy Electron Inactivated Respiratory Syncytial Virus Vaccine Shows Protective Efficacy in an Animal Model

  2023cites this paper
• Low circulation of respiratory syncytial and influenza viruses during autumn-winter 2021 in the industrial workplace and long-term healthcare facilities in Athens, Greece

  2023cites this paper
• Host Responses to Respiratory Syncytial Virus Infection

  2023cites this paper
• Propagation of human respiratory syncytial virus in cells derived from the black flying fox (Pteropus alecto)

  2023cites this paper
• FROM CORONAVIRUSES TO CORONAVIRUSES

  2023cites this paper
• Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)

  2023cites this paper
• Epidemiology and molecular characteristics of respiratory syncytial virus (RSV) among italian community-dwelling adults, 2021/22 season

  2023cites this paper
• Preventative therapies for respiratory Syncytial virus (RSV) in children: Where are we now?

  2023cites this paper
• Biochemistry of the Respiratory Syncytial Virus L Protein Embedding RNA Polymerase and Capping Activities

  2023cites this paper
• Spatial resolution of virus replication: RSV and cytoplasmic inclusion bodies.

  2023cites this paper
• Global Burden and Trends of Respiratory Syncytial Virus Infection Across Different Age Groups from 1990 to 2019: A Systematic Analysis of the Global Burden of Disease 2019 Study.

  2023cites this paper
• High-throughput screening of genetic and cellular drivers of syncytium formation induced by the spike protein of SARS-CoV-2

  2023cites this paper
• Temporal Shift of the Respiratory Syncytial Virus Epidemic Peak for the Years 2020–2023 in Marseille, Southern France

  2023cites this paper
• N 6-methyladenosine modification contributes to respiratory syncytial virus infection.

  2023cites this paper
• Current situation and future perspectives of vaccines against respiratory syncytial virus

  2023cites this paper
• The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist/immunologist.

  2023cites this paper
• Nirsevimab: Towards universal child immunization against respiratory syncytial virus

  2023cites this paper
• A trajectory of the FDA approval of the first vaccine targeting RSV: A greek tragedy with a happy ending.

  2023cites this paper
• Genealogy of an in-vivo passaged isolate of western Canadian bovine respiratory syncytial virus.

  2022cites this paper
• Impact of genetic polymorphisms related to innate immune response on respiratory syncytial virus infection in children

  2022cites this paper
• Prefusion-specific antibody-derived peptides trivalently presented on DNA-nanoscaffolds as an innovative strategy against RSV entry

  2022cites this paper
• From animal studies into clinical trials: the relevance of animal models to develop vaccines and therapies to reduce disease severity and prevent hRSV infection

  2022cites this paper
• Burden and disease pathogenesis of influenza and other respiratory viruses in diabetic patients.

  2022cites this paper
• Innate Immune Evasion by Human Respiratory Syncytial Virus

  2022cites this paper
• Preliminary data on messenger RNA (mRNA) vaccines against respiratory syncytial virus

  2022cites this paper
• Nirsevimab: hacia la inmunización universal de la población infantil frente al virus respiratorio sincitial

  2022cites this paper
• Early innate immune response triggered by the human respiratory syncytial virus and its regulation by ubiquitination/deubiquitination processes

  2022cites this paper
• Exploring Key Genes and Mechanisms in Respiratory Syncytial Virus-Infected BALB/c Mice via Multi-Organ Expression Profiles

  2022cites this paper
• Clinical and biological consequences of respiratory syncytial virus genetic diversity

  2022cites this paper
• Global distribution of respiratory syncytial virus A and B infections: a systematic review

  2022cites this paper
• EDP-938, un nuevo antiviral con actividad inhibidora frente a la nucleoproteína del virus respiratorio sincitial

  2022cites this paper
• Human parainfluenza 3 and respiratory syncytial viruses detected in pangolins

  2022cites this paper
• A Safe and Effective Mucosal RSV Vaccine Consisting of RSV Phosphoprotein and Flagellin Variant

  2021cites this paper
• Qingfei oral liquid inhibited autophagy to alleviate inflammation via mTOR signaling pathway in RSV-infected asthmatic mice.

  2021cites this paper
• Reverse genetics systems for contemporary isolates of respiratory syncytial virus enable rapid evaluation of antibody escape mutants

  2021cites this paper